S
Samuel W. Greenhouse
Researcher at George Washington University
Publications - 49
Citations - 7765
Samuel W. Greenhouse is an academic researcher from George Washington University. The author has contributed to research in topics: Myocardial infarction & Aminopterin. The author has an hindex of 24, co-authored 49 publications receiving 7488 citations. Previous affiliations of Samuel W. Greenhouse include Brookhaven National Laboratory & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
On methods in the analysis of profile data.
TL;DR: In this article, an approximate procedure based on classical analysis of variance is presented, including an adjustment to the degrees of freedom resulting in conservative F tests, which can be applied to the case where the variance covariance matrices differ from group to group.
Journal ArticleDOI
An Extension of Box's Results on the Use of the $F$ Distribution in Multivariate Analysis
TL;DR: In this article, the authors show that the treatment mean square and the treatment group interaction can be tested in the same approximate fashion by using the Box procedure, and that the conservative test would be $F(1, n - 1).
Journal ArticleDOI
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial
Allan M. Ross,Karin S. Coyne,Jonathan S. Reiner,Samuel W. Greenhouse,Cynthia A. Fink,Anthony Frey,Eduardo Moreyra,Mouhieddin Traboulsi,Normand Racine,Arthur L. Riba,Mark A Thompson,Steven Rohrbeck,Conor F. Lundergan +12 more
TL;DR: Tailored thrombolytic regimens compatible with subsequent interventions lead to more frequent early recanalization (before cath arrival), which facilitates greater LV function preservation with no augmentation of adverse events.
Journal ArticleDOI
Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience
Scott L. Woodfield,Conor F. Lundergan,Jonathan S. Reiner,Samuel W. Greenhouse,Mark A. Thompson,Steven Rohrbeck,Yuri A. Deychak,Maarten L. Simoons,Robert M. Califf,Eric J. Topol,Allan M. Ross +10 more
TL;DR: Early (90-min) infarct-related artery patency as well as regional and global ventricular function do not differ between patients with and without diabetes after thrombolytic therapy, except for reduced compensatory hyperkinesia in the noninfarct zone among patients with diabetes.
Journal ArticleDOI
Extended Mortality Benefit of Early Postinfarction Reperfusion
Allan M. Ross,Karin S. Coyne,E Moreyra,Jonathan S. Reiner,Samuel W. Greenhouse,Pamela L. Walker,Maarten L. Simoons,Yasmine C. Draoui,Robert M. Califf,Eric J. Topol,F. Van de Werf,Conor F. Lundergan +11 more
TL;DR: A substantial mortality advantage for early complete reperfusion (Thrombolysis in Myocardial Infarction [TIMI] grade 3) and for preserved ejection fraction occurred beyond 30 days.